Form 4 for EW Edwards Lifesciences
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-21 · accession 0001225208-23-002469 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-21 | 2023-02-21 | EW | Ullem Scott B. | CFO, CVP | F - Tax | $78.51 | -335 | 17.8K | -2% | -$26.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-21 | F | D | 335 | $78.51 | 17,784 | D | — | — |